Brief: Inflarx Reports Full Year 2022 Financial And Operating Results
22/03/2023 11:33
March 22 (Reuters) - InflaRx NV IF0G.F :
* INFLARX REPORTS FULL YEAR 2022 FINANCIAL AND OPERATING
RESULTS
* INFLARX NV FY LOSS PER SHARE EUR 0.67
* INFLARX NV - TOTAL FUNDS AVAILABLE APPROXIMATELY €83.7
MILLION
AS OF DECEMBER 31, 2022, FUNDING THE COMPANY INTO H2 2025
Source text for Eikon: ID:nGNX5xzmdZ
Further company coverage: IF0G.F
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Inflarx NV
See all newsBrief: Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing
Brief: InflaRx Reports Full Year 2025 Results And Highlights Key Achievements And Expected Milestones
Brief: Inflarx Announces Late-Breaker Oral Presentation On Vilobelimab Phase 3 Results In Pyoderma Gangrenosum At 2026 American Academy Of Dermatology Annual Meeting
Brief: Inflarx NV Executing 30% Workforce Reduction
Brief: Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum